| Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence ST Cole, R Brosch, J Parkhill, T Garnier, C Churcher, D Harris, SV Gordon, ... Nature 396 (6707), 190-190, 1998 | 10365 | 1998 |
| The spectrum of latent tuberculosis: rethinking the biology and intervention strategies CE Barry 3rd, HI Boshoff, V Dartois, T Dick, S Ehrt, JA Flynn, ... Nature Reviews Microbiology 7 (12), 845-855, 2009 | 1717 | 2009 |
| A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis CK Stover, P Warrener, DR VanDevanter, DR Sherman, TM Arain, ... Nature 405 (6789), 962-966, 2000 | 1323 | 2000 |
| A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response MB Reed, P Domenech, C Manca, H Su, AK Barczak, BN Kreiswirth, ... Nature 431 (7004), 84-87, 2004 | 947 | 2004 |
| Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk KD Mayer-Barber, BB Andrade, SD Oland, EP Amaral, DL Barber, ... Nature 511 (7507), 99-103, 2014 | 850 | 2014 |
| PA-824 Kills Nonreplicating Mycobacterium tuberculosis by Intracellular NO Release R Singh, U Manjunatha, HIM Boshoff, YH Ha, P Niyomrattanakit, ... Science 322 (5906), 1392-1395, 2008 | 815 | 2008 |
| Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-α/β C Manca, L Tsenova, A Bergtold, S Freeman, M Tovey, JM Musser, ... Proceedings of the National Academy of Sciences 98 (10), 5752-5757, 2001 | 785 | 2001 |
| Mycolic acids: structure, biosynthesis and physiological functions CE Barry Iii, RE Lee, K Mdluli, AE Sampson, BG Schroeder, RA Slayden, ... Progress in lipid research 37 (2-3), 143-179, 1998 | 777 | 1998 |
| Tuberculous granulomas are hypoxic in guinea pigs, rabbits, and nonhuman primates LE Via, PL Lin, SM Ray, J Carrillo, SS Allen, SY Eum, K Taylor, E Klein, ... Infection and immunity 76 (6), 2333-2340, 2008 | 759 | 2008 |
| The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism: novel insights into drug mechanisms of action HIM Boshoff, TG Myers, BR Copp, MR McNeil, MA Wilson, CE Barry Journal of Biological Chemistry 279 (38), 40174-40184, 2004 | 753 | 2004 |
| Linezolid for treatment of chronic extensively drug-resistant tuberculosis M Lee, J Lee, MW Carroll, H Choi, S Min, T Song, LE Via, LC Goldfeder, ... New England Journal of Medicine 367 (16), 1508-1518, 2012 | 727 | 2012 |
| Pyrazinamide Inhibits Trans-Translation in Mycobacterium tuberculosis W Shi, X Zhang, X Jiang, H Yuan, JS Lee, CE Barry 3rd, H Wang, ... Science 333 (6049), 1630-1632, 2011 | 717 | 2011 |
| Tuberculosis: what we don’t know can, and does, hurt us DG Russell, CE Barry 3rd, JAL Flynn Science 328 (5980), 852-856, 2010 | 701 | 2010 |
| The salicylate-derived mycobactin siderophores of Mycobacterium tuberculosis are essential for growth in macrophages JJ De Voss, K Rutter, BG Schroeder, H Su, YQ Zhu, CE Barry III Proceedings of the National Academy of Sciences 97 (3), 1252-1257, 2000 | 679 | 2000 |
| Meropenem-Clavulanate Is Effective Against Extensively Drug-Resistant Mycobacterium tuberculosis JE Hugonnet, LW Tremblay, HI Boshoff, CE Barry 3rd, JS Blanchard Science 323 (5918), 1215-1218, 2009 | 625 | 2009 |
| Neutrophils are the predominant infected phagocytic cells in the airways of patients with active pulmonary TB SY Eum, JH Kong, MS Hong, YJ Lee, JH Kim, SH Hwang, SN Cho, LE Via, ... Chest 137 (1), 122-128, 2010 | 624 | 2010 |
| Inhibition of a Mycobacterium tuberculosis β-Ketoacyl ACP Synthase by Isoniazid K Mdluli, RA Slayden, YQ Zhu, S Ramaswamy, X Pan, D Mead, DD Crane, ... Science 280 (5369), 1607-1610, 1998 | 618 | 1998 |
| Evolutionary history and global spread of the Mycobacterium tuberculosis Beijing lineage M Merker, C Blin, S Mona, N Duforet-Frebourg, S Lecher, E Willery, ... Nature genetics 47 (3), 242-249, 2015 | 603 | 2015 |
| Tuberculosis—metabolism and respiration in the absence of growth HIM Boshoff, CE Barry 3rd Nature Reviews Microbiology 3 (1), 70-80, 2005 | 593 | 2005 |
| SQ109 targets MmpL3, a membrane transporter of trehalose monomycolate involved in mycolic acid donation to the cell wall core of Mycobacterium tuberculosis K Tahlan, R Wilson, DB Kastrinsky, K Arora, V Nair, E Fischer, SW Barnes, ... Antimicrobial agents and chemotherapy 56 (4), 1797-1809, 2012 | 592 | 2012 |